MedPath

A Mindfulness Approach to UA for Afro-descendants

Not Applicable
Completed
Conditions
Stress
Anxiety
Interventions
Behavioral: App-Delivered Mindfulness Training (MT)
Registration Number
NCT05881681
Lead Sponsor
Brown University
Brief Summary

The goal of this clinical trial is to test an app-based mindfulness training program in an Afro-descendant population. The main question\[s\] it aims to answer are:

* What changes, if any, does the app need?

* Is it effective in reducing anxiety among this population?

Participants will be asked to:

* Use an app-based mindfulness training program daily

* Complete online surveys at baseline and 2 months post-treatment initiation

* Complete focused interviews via Zoom at baseline and 2 months post-treatment initiation

* Complete daily voice diaries via Zoom

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • GAD-7 ≥ 10
  • Self-identify as Black American and/or Afro-descendant
  • Located in United States or Canada
  • Able to speak English
  • Owns a smartphone
Exclusion Criteria
  • Any usage of psychotropic medication: not on a stable dosage 6+ weeks
  • As needed (i.e., prn) benzodiazepine use
  • Psychotic disorder (e.g., bipolar disorder, schizophrenia, schizoaffective disorder, psychosis)
  • Cohabiting with a study participant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
App-Delivered Mindfulness Training (MT)App-Delivered Mindfulness Training (MT)The Unwinding Anxiety program is delivered via a smartphone-based platform, which includes a progression through 30+ daily modules of brief didactic and experience-based mindfulness training (videos and animations), app-triggered check-ins to encourage engagement, and user-initiated guided mindfulness exercises to help disrupt worry cycles in the moment.
Primary Outcome Measures
NameTimeMethod
Focused interviews2 months

In-depth interviews will be conducted to collect participant feedback.

Secondary Outcome Measures
NameTimeMethod
Change in worryBaseline, 2 months

Penn State Worry Questionnaire (PSWQ) will be used to assess worry. The PSWQ is a 16-item questionnaire that uses a 5-point Likert scale where 1 is "Not at all typical of me" and 5 is "Very typical of me". Scores can range from 16 to 80 and higher scores indicate a worse outcome

Change in anxietyBaseline, 2 months

Generalized Anxiety Disorder 7-item will be used to assess anxiety. The GAD-7 is a 7-item questionnaire that uses a 4-point Likert scale where 0 is "Not at all" and 3 is "Nearly every day". Scores can range from 0 to 21 and higher scores indicated a worse outcome.

Change in non-reactivityBaseline, 2 months

Non-reactivity subscale from the 15-item Five Facet Mindfulness Questionnaire (FFMQ) will be used to measure changes in emotional reactivity. This subscale is based on responses to 3 questions measured on a 5-point Likert scale where 1 is "Never or rarely" and 5 is "Very often or always true". Scores can range from 3 to 15 and higher scores indicate a better outcome.

Trial Locations

Locations (1)

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath